ARTICLE | Company News
Clinical Data neurology news
May 22, 2006 7:00 AM UTC
CLDA plans to spin out Phase III compound vilazodone into newco Precigen. The mixed selective serotonin reuptake inhibitor (SSRI) and partial 5-HT1A agonist is in a Phase III trial for depression, wi...